Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcriptselective translational control

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 4, 2011, Pages 1415-1420

  Arif, Abul ^a   Jia, Jie ^a   Moodt, Robyn A ^a   DiCorleto, Paul E ^a   Fox, Paul L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 5 ACTIVATOR 1; ENZYME ACTIVATOR; GAMMA INTERFERON ACTIVATED INHIBITOR OF TRANSLATION; GLUTAMATE TRANSFER RNA LIGASE; GLUTAMYLPROLINE TRANSFER RNA LIGASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INHIBITOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NS1 ASSOCIATED PROTEIN; PROTEIN; RIBOSOMAL PROTEIN L13A; RIBOSOME PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ARTICLE; BONE MARROW CELL; ENZYME ACTIVATION; ENZYME BINDING; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; REGULON; TRANSLATION REGULATION;

AMINO ACYL-TRNA SYNTHETASES; CYCLIN-DEPENDENT KINASE 5; HUMANS; IMMUNOBLOTTING; INTERFERON-GAMMA; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA INTERFERENCE; SERINE; TRANSCRIPTION, GENETIC; U937 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952129827     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1011275108     Document Type: Article

References (40)

1. Ibba M, Söll D (2000) Aminoacyl-tRNA synthesis. Annu Rev Biochem 69:617-650.
2. Ribas de Pouplana L, Schimmel P (2001) Aminoacyl-tRNA synthetases: Potential markers of genetic code development. Trends Biochem Sci 26:591-596. (Pubitemid 32925189)
3. Guo M, Schimmel P, Yang XL (2010) Functional expansion of human tRNA synthetases achieved by structural inventions. FEBS Lett 584:434-442.
4. Lee SW, Cho BH, Park SG, Kim S (2004) Aminoacyl-tRNA synthetase complexes: Beyond translation. J Cell Sci 117:3725-3734. (Pubitemid 39207312)
5. Clemens MJ (1990) Does protein phosphorylation play a role in translational control by eukaryotic aminoacyl-tRNA synthetases? Trends Biochem Sci 15:172-175.
6. 4A) synthesis. J Biol Chem 264:5861-5865.
7. Yannay-Cohen N, et al. (2009) LysRS serves as a key signaling molecule in the immune response by regulating gene expression. Mol Cell 34:603-611.
8. Sampath P, et al. (2004) Noncanonical function of glutamyl-prolyl-tRNA synthetase: Gene-specific silencing of translation. Cell 119:195-208. (Pubitemid 39360902)
9. Arif A, et al. (2009) Two-site phosphorylation of EPRS coordinates multimodal regulation of noncanonical translational control activity. Mol Cell 35:164-180.
10. Ray PS, Arif A, Fox PL (2007) Macromolecular complexes as depots for releasable regulatory proteins. Trends Biochem Sci 32:158-164. (Pubitemid 46603279)
11. Ray PS, Fox PL (2007) A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity. EMBO J 26:3360-3372. (Pubitemid 47123539)
12. Mukhopadhyay R, Jia J, Arif A, Ray PS, Fox PL (2009) The GAIT system: A gatekeeper of inflammatory gene expression. Trends Biochem Sci 34:324-331.
13. Jia J, Arif A, Ray PS, Fox PL (2008) WHEP domains direct noncanonical function of glutamyl-Prolyl tRNA synthetase in translational control of gene expression. Mol Cell 29:679-690. (Pubitemid 351400920)
14. Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH (1998) p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5), is degraded by the ubiquitin-proteasome pathway. J Biol Chem 273:24057-24064. (Pubitemid 28435748)
15. Kitzmann M, et al. (1999) cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: Role in modulating MyoD half-life and myogenic activity. Mol Cell Biol 19:3167-3176. (Pubitemid 29144561)
16. Tsai LH, Takahashi T, Caviness VS, Jr., Harlow E (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029-1040. (Pubitemid 23358574)
17. Ohshima T, et al. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173-11178. (Pubitemid 26333137)
18. Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2:749-759. (Pubitemid 33679837)
19. Lalioti V, Pulido D, Sandoval IV (2010) Cdk5, the multifunctional surveyor. Cell Cycle 9:284-311.
20. Rosales JL, Lee KY (2006) Extraneuronal roles of cyclin-dependent kinase 5. Bioessays 28:1023-1034. (Pubitemid 44570451)
21. Ko J, et al. (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-6771. (Pubitemid 32781119)
22. Harada T, Morooka T, Ogawa S, Nishida E (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 3:453-459. (Pubitemid 32422080)
23. Chen F, Wang Q, Wang X, Studzinski GP (2004) Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclindependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation. Cancer Res 64:5425-5433. (Pubitemid 39006565)
24. Song JH, et al. (2005) Interferon-. induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of the ERK1/2 pathway. J Biol Chem 280:12896-12901.
25. Ray PS, et al. (2009) A stress-responsive RNA switch regulates VEGFA expression. Nature 457:915-919.
26. Antonellis A, Green ED (2008) The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 9:87-107.
27. Park SG, Schimmel P, Kim S (2008) Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci USA 105:11043-11049.
28. Antonellis A, et al. (2003) Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 72:1293-1299. (Pubitemid 36530017)
29. Jordanova A, et al. (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38:197-202. (Pubitemid 43177233)
30. Kunst CB, Mezey E, Brownstein MJ, Patterson D (1997) Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 15:91-94. (Pubitemid 27014957)
31. Park SG, et al. (2005) Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc Natl Acad Sci USA 102:6356-6361.
32. Li Y, et al. (2004) Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci USA 101:15688-15693. (Pubitemid 39473549)
33. Li Y, et al. (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 15:2560-2568. (Pubitemid 44288686)
34. Lee KY, et al. (1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34:21-29.
35. Saxena R, et al.; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336.
36. Ubeda M, Kemp DM, Habener JF (2004) Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells. Endocrinology 145:3023-3031. (Pubitemid 38686252)
37. Wei FY, et al. (2005) Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med 11:1104-1108.
38. Takahashi S, et al. (2010) Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration. Am J Pathol 176:320-329.
39. Choi HS, et al. (2009) Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population. J Hum Genet 54:298-303.
40. Chen F, Studzinski GP (2001) Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood 97:3763-3767.